A macrophage-targeted platform for extending drug dosing with polymer prodrugs for pulmonary infection prophylaxis-Reference-Cited by-同舟云学术

A macrophage-targeted platform for extending drug dosing with polymer prodrugs for pulmonary infection prophylaxis

Published:2021-02 Issue: Volume:330 Page:284-292
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Chavas Thomas E.J.,Su Fang-Yi,Srinivasan Selvi,Roy Debashish,Lee Brian,Lovelace-Macon Lara,Rerolle Guilhem F.,Limqueco Elaine,Skerrett Shawn J.,Ratner Daniel M.,West T. Eoin,Stayton Patrick S.

Funder

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference61 articles.

1. Antimicrobial therapies for Q fever;Kersh;Expert Rev. Anti-Infect. Ther.,2013

2. Drug resistance in influenza A virus: the epidemiology and management;Hussain;Infect. Drug Resist.,2017

3. Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment;Koch;Curr. Opin. Pharmacol.,2018

4. Legionellosis, Infections of the Central Nervous System;Johnson,2020

5. Pulmonary non-tuberculous mycobacterial infections: current state and future management;Chin;Eur. J. Clin. Microbiol. Infect. Dis.,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments in synthetic approaches for macromolecular prodrugs;Progress in Polymer Science;2024-08

2. Nanofluidic delivery implant sustains localization and maximizes efficacy of intratumoral immunotherapy;Nano Today;2024-06

3. Machine learning and bioinformatics to identify biomarkers in response to <i>Burkholderia pseudomallei</i> infection in mice;BIOCELL;2024

4. Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy;Advanced Drug Delivery Reviews;2023-11

5. Alveolar macrophages in tissue homeostasis, inflammation, and infection: evolving concepts of therapeutic targeting;Journal of Clinical Investigation;2023-10-02